HCA Healthcare Inc (HCA) Stake Decreased by Victory Capital Management Inc.

Victory Capital Management Inc. reduced its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 40.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 682,928 shares of the company’s stock after selling 455,914 shares during the period. Victory Capital Management Inc.’s holdings in HCA Healthcare were worth $95,009,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in HCA. DnB Asset Management AS lifted its holdings in shares of HCA Healthcare by 5.6% during the 2nd quarter. DnB Asset Management AS now owns 35,944 shares of the company’s stock worth $3,688,000 after acquiring an additional 1,900 shares during the period. IFM Investors Pty Ltd lifted its holdings in shares of HCA Healthcare by 44.1% during the 2nd quarter. IFM Investors Pty Ltd now owns 12,531 shares of the company’s stock worth $1,286,000 after acquiring an additional 3,834 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of HCA Healthcare by 27.7% during the 2nd quarter. State of Alaska Department of Revenue now owns 45,700 shares of the company’s stock worth $4,687,000 after acquiring an additional 9,910 shares during the period. Confluence Investment Management LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth about $283,000. Finally, NN Investment Partners Holdings N.V. lifted its holdings in shares of HCA Healthcare by 198.9% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 170,204 shares of the company’s stock worth $17,463,000 after acquiring an additional 113,265 shares during the period. Institutional investors and hedge funds own 70.48% of the company’s stock.

HCA opened at $134.44 on Friday. HCA Healthcare Inc has a 1 year low of $74.26 and a 1 year high of $141.11. The company has a market cap of $46.52 billion, a P/E ratio of 15.11, a price-to-earnings-growth ratio of 1.18 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. During the same quarter last year, the company earned $1.13 earnings per share. HCA Healthcare’s revenue for the quarter was up 7.1% on a year-over-year basis. Analysts expect that HCA Healthcare Inc will post 9.33 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be given a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 1.04%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is 21.24%.

In other HCA Healthcare news, SVP Jane D. Englebright sold 6,543 shares of the stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total value of $849,673.98. Following the completion of the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at $966,547.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael S. Cuffe sold 5,196 shares of the stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total transaction of $709,357.92. The disclosure for this sale can be found here. 2.80% of the stock is owned by company insiders.

Several brokerages have recently weighed in on HCA. SunTrust Banks increased their price objective on shares of HCA Healthcare to $150.00 and gave the stock a “positive” rating in a report on Tuesday, September 4th. Credit Suisse Group increased their price objective on shares of HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a report on Thursday. Citigroup increased their price objective on shares of HCA Healthcare from $136.00 to $156.00 and gave the stock a “buy” rating in a report on Thursday, October 11th. Jefferies Financial Group increased their price objective on shares of HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Mizuho set a $150.00 target price on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Tuesday, September 4th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $141.26.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: NASDAQ Stock Market Explained

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply